Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

2.82

Margin Of Safety %

-13

Put/Call OI Ratio

0.51

EPS Next Q Diff

-0.06

EPS Last/This Y

-0.66

EPS This/Next Y

1.18

Price

134.58

Target Price

200.3

Analyst Recom

1.39

Performance Q

-11.09

Relative Volume

0.87

Beta

1.76

Ticker: NTRA




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04NTRA161.30.350.1410582
2025-07-07NTRA158.750.352.6410524
2025-07-08NTRA158.480.381.5710813
2025-07-09NTRA161.810.394.1810928
2025-07-10NTRA163.390.451.9211430
2025-07-11NTRA160.490.456.1511486
2025-07-14NTRA158.210.494.9811742
2025-07-15NTRA149.760.531.8212117
2025-07-16NTRA148.370.550.4513210
2025-07-17NTRA143.420.561.4414523
2025-07-18NTRA138.830.530.1214493
2025-07-21NTRA140.670.500.0711854
2025-07-22NTRA139.910.450.2912785
2025-07-23NTRA137.810.450.7412823
2025-07-24NTRA141.180.451.2812941
2025-07-25NTRA138.880.4713.4813170
2025-07-28NTRA138.260.531.2013804
2025-07-29NTRA135.810.540.0813950
2025-07-30NTRA140.950.530.1314104
2025-07-31NTRA133.570.520.1614294
2025-08-01NTRA134.510.510.6214405
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04NTRA161.76-101.8-185.5-2.22
2025-07-07NTRA158.73-101.8-178.0-2.22
2025-07-08NTRA158.48-101.8-184.6-2.22
2025-07-09NTRA161.75-101.8-192.9-2.22
2025-07-10NTRA163.36-101.8-188.9-2.22
2025-07-11NTRA160.43-101.8-182.0-2.22
2025-07-14NTRA158.18-101.8-179.8-2.22
2025-07-15NTRA149.85-101.8-165.1-2.22
2025-07-16NTRA148.37-101.8-181.3-2.22
2025-07-17NTRA143.38-101.8-172.2-2.22
2025-07-18NTRA138.90-101.8-173.2-2.22
2025-07-21NTRA140.65-101.8-189.9-2.22
2025-07-22NTRA139.87-101.8-183.0-2.22
2025-07-23NTRA137.82-101.8-179.4-2.22
2025-07-24NTRA141.07-98.1-194.1-2.16
2025-07-25NTRA138.90-98.1-179.2-2.16
2025-07-28NTRA138.25-98.1-183.3-2.16
2025-07-29NTRA135.84-98.1-179.1-2.16
2025-07-30NTRA140.96-98.1-199.9-2.16
2025-07-31NTRA133.66-98.1-165.3-2.19
2025-08-01NTRA134.58-98.1-187.7-2.19
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04NTRA-7.923.804.82
2025-07-07NTRA-7.923.794.82
2025-07-08NTRA-7.913.794.82
2025-07-09NTRA-7.913.794.82
2025-07-10NTRA-7.923.794.82
2025-07-11NTRA-7.853.794.90
2025-07-14NTRA-7.853.834.90
2025-07-15NTRA-7.853.834.90
2025-07-16NTRA-7.853.834.90
2025-07-17NTRA-7.853.834.90
2025-07-18NTRA-7.853.834.90
2025-07-21NTRA-7.883.474.90
2025-07-22NTRA-7.883.474.90
2025-07-23NTRA-6.673.474.90
2025-07-24NTRA-6.673.474.90
2025-07-25NTRA-6.123.472.87
2025-07-28NTRA-6.125.562.82
2025-07-29NTRA-8.635.562.82
2025-07-30NTRA-8.615.562.82
2025-07-31NTRA-8.935.562.82
2025-08-01NTRA-8.245.562.82
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.5

Avg. EPS Est. Current Quarter

-0.61

Avg. EPS Est. Next Quarter

-0.56

Insider Transactions

-8.24

Institutional Transactions

5.56

Beta

1.76

Average Sales Estimate Current Quarter

476

Average Sales Estimate Next Quarter

500

Fair Value

117.18

Quality Score

48

Growth Score

63

Sentiment Score

55

Actual DrawDown %

26.5

Max Drawdown 5-Year %

-77.7

Target Price

200.3

P/E

Forward P/E

PEG

P/S

10.04

P/B

14.76

P/Free Cash Flow

215.71

EPS

-1.47

Average EPS Est. Cur. Y​

-2.19

EPS Next Y. (Est.)

-1.01

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-10.36

Relative Volume

0.87

Return on Equity vs Sector %

-39

Return on Equity vs Industry %

-25.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

-187.7
Natera, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 4424
Natera, Inc., a diagnostics company, provides molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera molecular residual disease test for assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based genomic profiling test, that provides insight into genomic alterations and biomarkers; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product. It serves independent laboratories, national and regional reference laboratories, medical centers and physician practices, research laboratories, and pharmaceutical companies through its direct sales force, and a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.
stock quote shares NTRA – Natera, Inc. Stock Price stock today
news today NTRA – Natera, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NTRA – Natera, Inc. yahoo finance google finance
stock history NTRA – Natera, Inc. invest stock market
stock prices NTRA premarket after hours
ticker NTRA fair value insiders trading